Introduction of L438V significantly decreased E1E2 fitness to mediate HCVpp or HCVcc entry into hepatoma cells (S5 Fig), which is consistent with the observed reduction in binding of 1a154_L438V sE2 to CD81 and SR-B1. This evidence concerns the gene SCARB1 and hepatocellular carcinoma.